University of Virginia
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Virginia sits in the top decile of US sponsors by registered trial count (#78 of 15,742 sponsors by registered trial count).
University of Virginia: 449 sponsored US clinical trials, 101 recruiting.
University of Virginia sponsors 449 registered US clinical trials on ClinicalTrials.gov, 101 of them currently recruiting, and 281 completed. 40 of these trials are in Phase 3-4 (later-stage) and 109 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 1 Diabetes Mellitus, with 9 trials.
Top-decile sponsor footprint
University of Virginia ranks in the top decile of sponsors by registered trial count (#78 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
281 of 317 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
449 total, page 8 of 9
New Treatment for Alcohol and Nicotine Dependence
NCT01182766
A Clinical Study of the Performance of a Glucose Blinding Protein-Based Continuous Glucose Monitor (GBP CGM)
NCT01469715
Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF)
NCT01462006
An Interactive Internet Intervention for Adults With Insomnia
NCT01438697
Evaluation of EUS-Guided 22 Gauge Core Biopsy Versus Fine-needle Aspiration for Suspected Pancreatic Neoplasms
NCT01673334
Reduce African-American Infant Mortality
NCT01361880
Rapid Radiation Therapy for Painful Osseous Metastatic Disease
NCT01391234
Text Messaging Intervention to Improve HIV Adherence in Rural Drug Users
NCT01343654
Assessment of Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition
NCT01428245
Comparison of a Water-soluble Topical Antimicrobial to Silver Sulfadiazine in Partial Thickness Burns
NCT01926392
The Impact of Fitness on Vascular Dysfunction in Adolescents With Type 1 Diabetes
NCT01337947
Clinical Trial of CBASP for Individuals With Co-occurring Chronic Depression and Alcohol Dependence
NCT01528748
Evaluation Of Mobile Gamma Camera Imaging For Sentinel Node Biopsy In Melanoma
NCT01531608
Pramlintide Combined With Model Predictive Control Algorithm
NCT01434862
MRI for Non-Invasive Imaging in Neonates and Children
NCT02163681
Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma
NCT01264731
Study of Menstrual Irregularities and Endometrial Pathology in Women Undergoing Bariatric Surgery
NCT01473186
Haptoglobin Polymorphism as a Determinant of Adverse Outcome After Cardiac Surgery in Diabetic Patients
NCT02771808
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
NCT01192503
Insulin Sensitivity, Impaired Counterregulation, and Glucose Variability
NCT01439672
Plethysmography as a Useful Intraoperative Monitor
NCT01843244
Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder Cancer
NCT01240824
Development of a Behavioral Observer for Type 1 Diabetes Mellitus
NCT01434030
Prenatal Education Video Study
NCT01623128
Randomized Evaluation of the Efficacy of Synvisc-One® for the Treatment of Patellofemoral Chondromalacia
NCT01771952
Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease
NCT01101269
Internet Intervention for Childhood Encopresis
NCT00767403
Hypoglycemia Prevention After Exercise in Adolescent T1DM Patients Using a Control to Range System
NCT01390259
Intravenous Ondansetron to Attenuate the Hypotensive, Bradycardic Response to Spinal Anesthesia in Healthy Parturients
NCT01414777
Feasibility Study of a Modular Control to Range System in Type 1 Diabetes Mellitus
NCT01418703
IRB-HSR# 13957: IV Lidocaine for Patients Undergoing Primary Breast Cancer Surgery:
NCT01204242
Expression of Angiogenic Factors in Myocardial Tissue
NCT01414621
Medications Development for the Treatment of Cannabis Related Disorders
NCT01204723
Cranial Electrical Stimulation Effects on Symptoms in Persons With Fibromyalgia
NCT00928720
IRB-HSR# 14296 The Use of the Intrathoracic Pressure Regulator (ITPR) to Improve Systemic Blood Pressure in Patient Undergoing CABG Surgery
NCT01205594
IRB-HSR# 14145 R,S Methadone: Analgesia and Pharmacokinetics in Adolescents Undergoing Scoliosis Correction
NCT01205256
Ultrasound Assessment During Exercise
NCT01015846
Effect of Metformin on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone
NCT01427595
IRB-HSR # 14073 Investigation of Pelvic Girdle Dysfunction in the Low Back Pain Population
NCT02950129
Improved Detection of Neonatal Sepsis Using a Targeted Biomarker Assay
NCT01120678
HydroCoil Cerebral Aneurysm Treatment Trial
NCT01195129
Premature Infant Exposure to Noise Generated by Respiratory Support
NCT01748214
Study to Determine if Gloving in Addition to Hand Hygiene Will Prevent Invasive Infections and Necrotizing Enterocolitis
NCT01729000
SIS Multicenter Study of Duration of Antibiotics for Intraabdominal Infection
NCT00657566
A Pilot Study of Intraoperative Gamma Camera Imaging During Sentinel Node Biopsy for Melanoma
NCT00912730
Improving the Sleep of Cancer Patients Using an Internet-Based Program
NCT00716872
New Medication Treatment for Stimulant Dependence
NCT00689572
Propofol for Pediatric Tracheal Intubation With Deep Anesthesia During Sevoflurane Induction
NCT01150838
Neurodevelopmental Outcomes and Fluconazole Prophylaxis
NCT00975949
Pilot Study of Closed-Loop Glucose Control in People With Type 1 Diabetes (BPK004)
NCT00977808
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 58 |
| Phase 2 | 51 |
| Phase 3 | 14 |
| Phase 4 | 26 |
Therapeutic Areas
What is open in the University of Virginia pipeline
101 recruiting of 449 indexed (22% open); 281 completed (63%).
Phase mix: 40 late (III/IV) vs 109 early (I/II) (early-phase heavy).
Top condition: Type 1 Diabetes Mellitus (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Virginia: open-pipeline peers nationwide
Peers matched on 449 registered trials and 22% open enrollment, not the therapeutic-area sidebar.
University of Virginia sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 449 trials (± recruiting share)
- Medical College of Wisconsin · 447 trials · 21% recruiting
- Alliance for Clinical Trials in Oncology · 446 trials · 7% recruiting
- Boston Children's Hospital · 462 trials · 24% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
Sponsors near 22% open enrollment (± trial volume)
- Ohio State University Comprehensive Cancer Center · 23% recruiting · 341 trials
- University of Delaware · 23% recruiting · 106 trials
- University of Oklahoma · 22% recruiting · 358 trials
- ALX Oncology · 22% recruiting · 9 trials
Related
What to do with this University of Virginia page
449 registered trials is a research-attention snapshot, not an endorsement of University of Virginia or any single study.
- 101 of University of Virginia's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 1 Diabetes Mellitus is the condition University of Virginia studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 1 Diabetes Mellitus trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Virginia pipeline card: 449 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.